by Sue Robbins | Oct 26, 2021 | Migraine
Read more here
by Sue Robbins | Feb 5, 2020 | Migraine
Adults with Migraine have new reason to be hopeful. 2019 saw FDA approval of new acute Migraine medications, and 2020 will be the year thousands of adults with Migraine with or without aura will get to try new meds like Ubrelvy (ubreogepant). Ubrelvy is an oral CGRP...
by Sue Robbins | Nov 8, 2019 | Migraine
Eli Lilly, Allergan and Biohaven have a lot riding on their forthcoming migraine launches, and now cost-effectiveness watchdog ICER has come out with some less-than-stellar findings from data supporting the drugs. The Institute for Clinical and Economic...